BRIEF-AEP Signs Agreement To Sell Distributed Resources Business To Basalt-July 2024-www.financetom.com

BRIEF-AEP Signs Agreement To Sell Distributed Resources Business To Basalt

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-AEP Signs Agreement To Sell Distributed Resources Business To Basalt

May 13, 2024 2:04 PM

May 13 (Reuters) - American Electric Power Company Inc ( AEP )

* AEP SIGNS AGREEMENT TO SELL DISTRIBUTED RESOURCES BUSINESS

BASALT

* AMERICAN ELECTRIC POWER COMPANY INC ( AEP ): EXPECTS TO NET

APPROXIMATELY $315 MILLION IN CASH AFTER TAXES AND TRANSACTION

FEES

Source text for Eikon:

Further company coverage:

Previous page： --Nvidia Shares Attempt Rebound Premarket Tuesday After Closing 6.7% Lower Monday Next page： OpenAI to cut access to tools for developers in China and other regions, Chinese state media says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Nvidia Shares Attempt Rebound Premarket Tuesday After Closing 6.7% Lower Monday

Jun 25, 2024

04:47 AM EDT, 06/25/2024 (MT Newswires) -- Price: 116.57, Change: +0.93, Percent Change: +0.84 ...

OpenAI to cut access to tools for developers in China and other regions, Chinese state media says

Jun 25, 2024

BEIJING, June 25 (Reuters) - ChatGPT maker OpenAI is planning to block access to technology used to build artificial intelligence products for entities in China and some other countries, a Chinese state-owned newspaper reported on Tuesday. ChatGPT is not available in mainland China but many Chinese startups have been able to access OpenAI's application programming interface (API) platform and use...

Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval

Jun 25, 2024

04:41 AM EDT, 06/25/2024 (MT Newswires) -- Halozyme Therapeutics ( HALO ) said Tuesday that Roche received European Commission marketing authorization of OCREVUS SC co-formulated with ENHANZE, Halozyme's proprietary recombinant human hyaluronidase enzyme, for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis. OCREVUS SC is a 10-minute injection that maintains the same twice-yearly schedule as the approved...

Novo Nordisk's Wegovy weight-loss drug approved in China

Jun 25, 2024

SHANGHAI (Reuters) -Novo Nordisk said on Tuesday its popular weight-loss drug Wegovy has been approved in China, paving the way for sales in the world's second-largest economy. Novo said in March that it would initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. The company did not immediately respond to a Reuters request for comment on...